Thesis Summary

Brookfield Business Partners (BBU) presents a value realization setup with multiple near-term catalysts converging in 2026, validated operational execution at portfolio companies, and management actively buying back stock at what they describe as a "material discount to NAV."

Near-Term Catalysts (High Conviction)

BRK Brazil IPO (LR 3.5)

Brazilian IPO market "opening up again" per management, with the business showing double-digit growth and winning new concessions. Listing actively progressed, likely monetization in 2026.

Latrobe Monetization (LR 3.0)

Regulatory hurdle cleared, "all options on table" for capital return. Business repositioned as fixed income asset manager commanding premium valuations. Another near-term exit opportunity.

Corporate Reorganization (LR 2.5)

LP → Corp conversion completing "over coming weeks" pending final regulatory approval (shareholder approval already obtained). Expected benefits: improved liquidity, index inclusion eligibility.

Operational Execution Validates Model

Clarios: 40% EBITDA Growth Since Acquisition (LR 3.0)

EBITDA up $700M since acquisition, with management guiding to "path to similar level of growth over next five years." Strong execution on operational efficiency, innovation, expanding critical mineral recovery. US manufacturing tax credits supplementing cash generation.

Nielsen Turnaround (LR 2.8)

$800M total cost savings ($250M in 2025 alone), margins up 350 bps, $90M annual interest savings from refinancing. Classic private equity operational playbook executing well.

Capital Allocation & Balance Sheet Strength

45x Tax Credits: $297M Annual Run Rate (LR 2.0)

$297M in 2025 (vs $271M prior year). Third-party verified, insured against policy changes. Management confident in collection through normal IRS channels with insurance backstop. Real cash, not accounting fiction.

Strong Capital Position (LR 1.8)

$2.6B liquidity, generated $2B+ proceeds in 2025, repaid $1B debt, deployed $700M in acquisitions, bought back $235M stock at "significant discount to intrinsic value." Committed to $250M buyback program.

Financial Performance: Same-Store Growth Positive (LR 1.5)

Headline EBITDA down ($2.4B vs $2.6B) due to ownership changes from partial sales, but same-store performance positive: Industrial +10%, Business Services +5%. Underlying operations healthy.

Market Setup

Stock at $35.02, up 62% over 1 year, trading at 87% of 52-week range. Forward P/E 60.38 appears rich but is artifact of LP structure reporting—irrelevant after corp conversion. Management explicitly states "material discount to NAV" and is actively buying back stock.

Analyst consensus bullish (83%), mean target $39.17 (+11.8% upside). Street hasn't priced in full catalyst stack (BRK IPO + Latrobe exit + corp conversion all happening in 2026).

Recent issuer buybacks ($4.7M + $3.0M on Dec 31) align with management commentary about discount to intrinsic value.

Investment Implication

This is a value realization setup with demonstrated operational execution, not a speculative bet. Two near-term monetizations (BRK IPO, Latrobe) that could crystallize the NAV discount, ongoing operational wins at portfolio companies (Clarios, Nielsen), strong balance sheet ($2.6B liquidity), and management actively buying back stock at what they view as a discount.

Multiple catalysts converging in 2026 with operational execution as the foundation. Deserves consideration for full thesis development and potential position sizing.